Skip to content

Clinical Study on the Treatment of Post-stroke Insomnia with the Acupuncture Method of "Open Xuanfu and release depression" Based on " Ying-wei’s contrary and obedient"

Clinical Study on the Treatment of Post-stroke Insomnia with the Acupuncture Method of "Open Xuanfu and release depression" Based on " Ying-wei’s contrary and obedient"

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078363
Enrollment
Unknown
Registered
2023-12-06
Start date
2023-11-22
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke Insomnia

Interventions

7-9 am acupuncture group:Acupuncture treatment
control group:Oral administration of Dezopiclone tablets
5-7 pm acupuncture group:Acupuncture treatment

Sponsors

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Age range from 18 to 75 years old; (2)Patients who meet the diagnostic criteria for stroke and insomnia; (3) Insomnia symptoms occur after stroke; (4) PSQI = 6 points; (5) Unconscious disorders, lack of obvious intelligence, language comprehension and expression disorders, able to independently complete various scale assessments; (6) Agree to participate in the investigation and sign a written informed consent form

Exclusion criteria

Exclusion criteria: (1) Patients with allergies to right zopiclone; (2) Insomnia caused by other diseases or lifestyle habits (such as alcoholism and drug dependence); Or those who rely on antipsychotic drugs; (3) Those with severe mental symptoms; (4) Patients who have participated in clinical research on other drugs within the past month or have used relevant sedatives within 2 weeks; (5)Individuals who are unable to communicate or have cognitive impairment; (6)Women who are pregnant during lactation, pregnancy, or possibly during the trial period; (7) Poor compliance after enrollment, unauthorized use of drugs or treatments other than those permitted by the trial, serious adverse reactions during treatment, loss of follow-up or refusal to continue participating in the trial.

Design outcomes

Primary

MeasureTime frame
PolySomnoGraphy;

Secondary

MeasureTime frame
Pittsburgh Sleep Quality Index Score;Hamilton Anxiety and Depression Scale;athens insomnia scale;

Countries

China

Contacts

Public ContactXiao Wu

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University

29434230@qq.com+86 138 8043 6122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026